{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:36:56Z","timestamp":1761709016335},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T00:00:00Z","timestamp":1418428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00120-014-3713-z","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T16:21:36Z","timestamp":1418314896000},"page":"52-61","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Retroperitoneale Fibrose","Retroperitoneal fibrosis"],"prefix":"10.1007","volume":"54","author":[{"given":"S.","family":"Kukuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kretschmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bruck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,13]]},"reference":[{"key":"3713_CR1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","volume":"367","author":"Vaglio","year":"2006","unstructured":"Vaglio A, Salvarani C, Buzio C (2006) Retroperitoneal fibrosis. Lancet 367(9506):241\u2013251","journal-title":"Lancet"},{"key":"3713_CR2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.juro.2010.09.105","volume":"185","author":"Brandt","year":"2011","unstructured":"Brandt AS, Kamper L, Kukuk S et al (2011) Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a urological registry. J Urol 185(2):526\u2013531","journal-title":"J Urol"},{"key":"3713_CR3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00120-008-1705-6","volume":"47","author":"Burkhardt","year":"2008","unstructured":"Burkhardt Soares S, Kukuk S, Brandt AS et al (2008) Retroperitoneal fibrosis. Urologe Ausg A 47(4):489\u2013499","journal-title":"Urologe Ausg A"},{"key":"3713_CR4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1055\/s-0031-1273450","volume":"183","author":"Kamper","year":"2011","unstructured":"Kamper L, Brandt AS, Ekamp H et al (2011) MR evaluation of retroperitoneal fibrosis. Rofo 183(8):721\u2013726","journal-title":"Rofo"},{"key":"3713_CR5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.2004.029793","volume":"64","author":"Warnatz","year":"2005","unstructured":"Warnatz K, Keskin AG, Uhl M et al (2005) Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis 64(6):828\u2013833","journal-title":"Ann Rheum Dis"},{"key":"3713_CR6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2559.1984.tb02371.x","volume":"8","author":"Mitchinson","year":"1984","unstructured":"Mitchinson MJ (1984) Chronic periaortitis and periarteritis. Histopathology 8(4):589\u2013600","journal-title":"Histopathology"},{"key":"3713_CR7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2559.1990.tb01541.x","volume":"16","author":"Parums","year":"1990","unstructured":"Parums DV (1990) The spectrum of chronic periaortitis. Histopathology 16(5):423\u2013431","journal-title":"Histopathology"},{"key":"3713_CR8","first-page":"383","volume":"114","author":"Parums","year":"1990","unstructured":"Parums DV, Brown DL, Mitchinson MJ (1990) Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med 114(4):383\u2013387","journal-title":"Arch Pathol Lab Med"},{"key":"3713_CR9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9343(03)00056-1","volume":"114","author":"Vaglio","year":"2003","unstructured":"Vaglio A, Corradi D, Manenti L et al (2003) Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 114(6):454\u2013462","journal-title":"Am J Med"},{"key":"3713_CR10","first-page":"772","volume":"30","author":"Binder","year":"2012","unstructured":"Binder M, Christoph S, Sehnert B et al (2012) Elevated serum osteopontin levels in idiopathic retroperitoneal fibrosis. Clin Exp Rheumatol 30(5):772\u2013775","journal-title":"Clin Exp Rheumatol"},{"key":"3713_CR11","first-page":"947","volume":"31","author":"Kihara","year":"2013","unstructured":"Kihara M, Sugihara T, Hosoya T et al (2013) Clinical significance of complement as a biomarker of disease activity in 4 cases of IgG4-related disease with retroperitoneal fibrosis. Clin Exp Rheumatol 31(6):947\u2013949","journal-title":"Clin Exp Rheumatol"},{"key":"3713_CR12","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3899\/jrheum.111143","volume":"39","author":"Kollert","year":"2012","unstructured":"Kollert F, Binder M, Probst C et al (2012) CCL18 \u2013 potential biomarker of fibroinflammatory activity in chronic periaortitis. J Rheumatol 39(7):1407\u20131412","journal-title":"J Rheumatol"},{"key":"3713_CR13","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/art.24461","volume":"61","author":"Magrey","year":"2009","unstructured":"Magrey MN, Husni ME, Kushner I, Calabrese LH (2009) Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? Arthritis Rheum 61(5):674\u2013679","journal-title":"Arthritis Rheum"},{"key":"3713_CR14","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/art.38032","volume":"65","author":"Vaglio","year":"2013","unstructured":"Vaglio A, Catanoso MG, Spaggiari L et al (2013) Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum 65(9):2469\u20132475","journal-title":"Arthritis Rheum"},{"key":"3713_CR15","first-page":"149","volume":"15","author":"Grigorescu","year":"2006","unstructured":"Grigorescu M (2006) Noninvasive biochemical markers of liver fibrosis. J Gastrointestin Liver Dis 15(2):149\u2013159","journal-title":"J Gastrointestin Liver Dis"},{"key":"3713_CR16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.healun.2008.02.018","volume":"27","author":"Milting","year":"2008","unstructured":"Milting H, Ellinghaus P, Seewald M et al (2008) Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices. J Heart Lung Transplant 27(6):589\u2013596","journal-title":"J Heart Lung Transplant"},{"key":"3713_CR17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2010.11.038","volume":"215","author":"Liabeuf","year":"2011","unstructured":"Liabeuf S, Barreto DV, Kretschmer A et al (2011) High circulating levels of large splice variants of tenascin-C is associated with mortality and cardiovascular disease in chronic kidney disease patients. Atherosclerosis 215(1):116\u2013124","journal-title":"Atherosclerosis"},{"key":"3713_CR18","doi-asserted-by":"crossref","unstructured":"Abraham D (2008) Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc? Rheumatology (Oxford) 47(Suppl 5):v8\u2013v9","DOI":"10.1093\/rheumatology\/ken278"},{"key":"3713_CR19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.108.844324","volume":"3","author":"Biolo","year":"2010","unstructured":"Biolo A, Fisch M, Balog J et al (2010) Episodes of acute heart failure syndrome are associated with increased levels of troponin and extracellular matrix markers. Circ Heart Fail 3(1):44\u201350","journal-title":"Circ Heart Fail"},{"key":"3713_CR20","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1572-0241.2004.30110.x","volume":"99","author":"Afdhal","year":"2004","unstructured":"Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99(6):1160\u20131174","journal-title":"Am J Gastroenterol"},{"key":"3713_CR21","doi-asserted-by":"crossref","unstructured":"Pelkmans LG, van Damme H, Hendriksz TR et al (2012) Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Nephrology, dialysis, transplantation 27(7):2819\u20132825","DOI":"10.1093\/ndt\/gfr779"},{"key":"3713_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.33549\/physiolres.930448","volume":"53","author":"Striz","year":"2004","unstructured":"Striz I, Trebichavsky I (2004) Calprotectin \u2013 a pleiotropic molecule in acute and chronic inflammation. Physiol Res 53(3):245\u2013253","journal-title":"Physiol Res"},{"key":"3713_CR23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10067-010-1610-4","volume":"30","author":"Hasegawa","year":"2011","unstructured":"Hasegawa M, Fujimoto M, Matsushita T et al (2011) Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis. Clin Rheumatol 30(2):231\u2013237","journal-title":"Clin Rheumatol"},{"key":"3713_CR24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2362.2010.02271.x","volume":"40","author":"Lorenzen","year":"2010","unstructured":"Lorenzen J, Kr\u00e4mer R, Kliem V et al (2010) Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease. Eur J Clin Invest 40(4):294\u2013300","journal-title":"Eur J Clin Invest"},{"key":"3713_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cvr\/cvt100","volume":"99","author":"Lopez","year":"2013","unstructured":"Lopez B, Gonz\u00e1lez A, Lindner D et al (2013) Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase? Cardiovasc Res 99(1):111\u2013120","journal-title":"Cardiovasc Res"},{"key":"3713_CR26","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/jid.2012.32","volume":"132","author":"Wu","year":"2012","unstructured":"Wu M, Schneider DJ, Mayes MD et al (2012) Osteopontin in systemic sclerosis and its role in dermal fibrosis. J Invest Dermatol 132(6):1605\u20131614","journal-title":"J Invest Dermatol"},{"key":"3713_CR27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/cclm-2013-0502","volume":"52","author":"Knudsen","year":"2014","unstructured":"Knudsen CS, Heickendorff L, Nexo E (2014) Measurement of amino terminal propeptide of type III procollagen (PIIINP) employing the ADVIA Centaur platform. Validation, reference interval and comparison to UniQ RIA. Clin Chem Lab Med 52(2):237\u2013241","journal-title":"Clin Chem Lab Med"},{"key":"3713_CR28","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s00018-011-0783-6","volume":"68","author":"Midwood","year":"2011","unstructured":"Midwood KS, Hussenet T, Langlois B et al (2011) Advances in tenascin-C biology. Cell Mol Life Sci 68(19):3175\u20133199","journal-title":"Cell Mol Life Sci"},{"key":"3713_CR29","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.201312-2221PP","volume":"189","author":"Selman","year":"2014","unstructured":"Selman M, Pardo A (2014) Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model. Am J Respir Crit Care Med 189(10):1161\u20131172","journal-title":"Am J Respir Crit Care Med"},{"key":"3713_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-5-15","volume":"5","author":"Fan","year":"2012","unstructured":"Fan D, Takawale A, Lee J et al (2012) Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 5(1):15","journal-title":"Fibrogenesis Tissue Repair"},{"key":"3713_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2261-11-77","volume":"11","author":"Kalogeropoulos","year":"2011","unstructured":"Kalogeropoulos AS, Tsiodras S, Rigopoulos AG et al (2011) Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation. BMC Cardiovasc Disord 11:77","journal-title":"BMC Cardiovasc Disord"},{"key":"3713_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/ar1454","volume":"7","author":"Kim","year":"2005","unstructured":"Kim WU, Min SY, Cho ML et al (2005) Elevated matrix metalloproteinase-9 in patients with systemic sclerosis. Arthritis Res Ther 7(1):71\u201379","journal-title":"Arthritis Res Ther"},{"key":"3713_CR33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/thorax.58.9.757","volume":"58","author":"Oshita","year":"2003","unstructured":"Oshita Y, Koga T, Kamimura T et al (2003) Increased circulating 92\u00a0kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma. Thorax 58(9):757\u2013760","journal-title":"Thorax"},{"key":"3713_CR34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2466-9-5","volume":"9","author":"Zakrzewicz","year":"2009","unstructured":"Zakrzewicz D, Eickelberg O (2009) From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases. BMC Pulm Med 9:5","journal-title":"BMC Pulm Med"},{"key":"3713_CR35","doi-asserted-by":"crossref","unstructured":"Pelsers MM, Hermens WT, Glatz JF (2005) Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 352(1\u20132):15\u201335","DOI":"10.1016\/j.cccn.2004.09.001"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-014-3713-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-014-3713-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-014-3713-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T16:16:13Z","timestamp":1690733773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-014-3713-z"}},"subtitle":["Entwicklung eines Biomarkerprofils zur Diagnostik und Verlaufskontrolle","Development of a biomarker profile for diagnosis and therapy monitoring"],"short-title":[],"issued":{"date-parts":[[2014,12,13]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["3713"],"URL":"https:\/\/doi.org\/10.1007\/s00120-014-3713-z","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,13]]}}}